Correction to: Infect Dis Ther https://doi.org/10.1007/s40121-021-00519-2

In the original publication of the article, figure 2 and the corresponding video were erroneously published. Fig. 2 and the video have now been corrected in the paper.

Fig. 2
figure 2

Summary of the MenACWY-CRM experience accrued during the first decade since its licensure. For more details, see video file 1 in the online/HTML version of the manuscript or follow the digital features link. *MenACWY-CRM inadvertently administered within 28 days prior to conception or during pregnancy. MenACWY-CRM is not indicated in pregnant women. MenACWY-CRM quadrivalent meningococcal vaccine against serogroups A, C, W and Y, conjugated to the nontoxic mutant of diphtheria toxin, HAV hepatitis A vaccine, HBV hepatitis B vaccine, Hib Haemophilus influenzae type b vaccine, IPV inactivated poliomyelitis vaccine, DTaP combined diphtheria, tetanus, acellular pertussis, PCV7 7-valent pneumococcal conjugate vaccine, PCV13 13-valent pneumococcal conjugate vaccine, Rotavirus rotavirus vaccine, MMR measles-mumps-rubella vaccine, V varicella vaccine, MMRV measles-mumps-rubella-varicella vaccine, Tdap tetanus-diphtheria-acellular pertussis vaccine, Td tetanus-diphtheria toxoid, HPV human papillomavirus vaccine, MenB Neisseria meningitidis serogroup B, 4CMenB multicomponent vaccine against meningococcal serogroup B, IMD invasive meningococcal disease